Evaluation of the Validity and Reliability of Muscle Ultrasound in the Detection of Undernutrition
Launched by HOPITAL FORCILLES · Apr 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of muscle ultrasound to detect undernutrition in hospitalized patients. Undernutrition is a serious condition that can lead to health problems and longer hospital stays, especially for patients with conditions like obesity, lung diseases, cancer, and gastrointestinal issues. The researchers want to find out if muscle ultrasound is a reliable tool to assess muscle function and help identify undernutrition in patients aged 18 to 70 who are receiving care for these conditions.
To participate in this trial, patients need to be admitted to a short-stay or follow-up care program for specific health issues and provide consent to join the study. They should not have any conditions that prevent the use of ultrasound or bioelectrical measurements, and they must not be pregnant or breastfeeding. If eligible, participants can expect to undergo muscle ultrasound tests, which are non-invasive and help evaluate their nutritional status. This research aims to improve the understanding of muscle health in relation to undernutrition, which could lead to better care for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted in short stay and follow-up care and rehabilitation of diabetology-obesity, pneumology, oncology and gastro-nutrition;
- • Age between 18 and 70 years at inclusion;
- • Affiliation with a social security system or beneficiary of such a system ;
- • Oral, free, informed and express consent of the patient or his/her family member.
- Exclusion Criteria:
- • Impossible to perform the ultrasound;
- • Impossibility of performing bioelectrical impedancemetry ;
- • Incapacity to consent;
- • Patient refusal to participate in the study;
- • Pregnancy (a pregnancy test should be performed if in doubt);
- • Breastfeeding woman;
- • Person subject to a safeguard of justice measure ;
- • Patient under guardianship or curatorship;
- • Patient in care limitation;
- • Sampling in the ineligible study group.
About Hopital Forcilles
Hopital Forcilles is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on patient safety and ethical standards, the hospital collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous studies across various therapeutic areas. By integrating cutting-edge technologies and methodologies, Hopital Forcilles aims to contribute significantly to the development of new treatments and therapies, ultimately enhancing health outcomes for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Férolles Attilly, Ile De France, France
Patients applied
Trial Officials
Aymeric LE NEINDRE, PhD
Principal Investigator
Hopital Forcilles
Virginie COLELLA, MSc
Study Director
Hopital Forcilles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported